Letter to the Editor: androgenetic alopecia; drug safety and therapeutic strategies
Expert Opin Drug Saf
.
2018 Jun;17(6):651-652.
doi: 10.1080/14740338.2018.1470744.
Epub 2018 May 9.
Authors
Gary Ong
1
,
Michael Manyak
2
,
Zrinka Lulic
1
Affiliations
1
b GlaxoSmithKline, Research & Development , Brentford , UK.
2
a GlaxoSmithKline, Research & Development , Research Triangle Park , North Carolina , USA.
PMID:
29707969
DOI:
10.1080/14740338.2018.1470744
No abstract available
Publication types
Comment
MeSH terms
Alopecia*
Finasteride*
Humans
Substances
Finasteride